Medtronic

The smartest money on Wall Street may be at the top hedge funds, whose investment managers are paid billions a year to beat the market. Those gurus only take big money clients, but you can follow their lead: DailyFinance has the 10 best stock picks of the 10 highest-paid hedge fund managers.

Among quarterly results scheduled for this holiday-shortened week, investors may be thankful for earnings results from Tyson Foods, the Arkansas-based poultry and meat producer. Analog Devices and Deere also are reporting.

While a new report from Goldman Sachs says health care is in a state of flux that most of the sector's companies haven't adjusted to yet, it also pinpoints four that have plenty of cash that could be put to good use for investors.

Here's news from the business world and other money matters to watch out for Wednesday (last updated at 8:00 a.m. Eastern time): Stocks Dive On Drop In Home Sales: Weak housing numbers sent stocks tumbling Tuesday in New York, after a report by the National Association of Realtors showed...

Medtronic, the world's largest medical device maker, reported fiscal first-quarter earnings Tuesday in line with Wall Street expectations, but weaker global demand for medical implants forced the company to slash 2011 earnings expectations.

Here's news from the business world and other money matters to watch out for Monday (last updated at 8:00 a.m. Eastern time): More Americans Tapping Retirement Savings: Mutual-fund giant Fidelity Investments reports the number of Americans seeking to withdraw money from savings set aside for...

The Food and Drug Administration is proposing to revamp its regulations of medical devices, the agency said Wednesday. While seeking to improve device safety, the FDA also wants to ease the regulatory environment and foster innovation. But the proposals have the industry concerned.

Federal regulators approved Novo Nordisk's new once-daily injection for treating Type 2 diabetes Victoza, driving shares higher. Shares of Amylin Pharmaceuticals also rallied as the approval of Victoza raises hopes that Amylin's rival drug will also get the greenlight.

President Obama can't be pleased by the loss of a Democratic Senate seat which jeopardizes passage of his cherished health-care reform. The news, however, appears to have fueled a mini stock rally in the health-care and pharma sectors wary of how any reform would affect their businesses. The uptrend is expected to continue.

Hewlett-Packard (HPQ) reported quarterly results Monday after the bell. There were few surprises, because the company had pre-announced them last week when it acquired 3Com, so the 14% profit rise boosted by China sales and better profit margins was mostly expected. However, H-P also announced it...